Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for Pregabalin
No pain, no gain: Plausibility in Warner-Lambert v Actavis No pain, no gain: Plausibility in Warner-Lambert v Actavis Reviewed by Dr Rose Hughes on Monday, November 26, 2018 Rating: 5

Friday Fantasies

IPKat is here with your update on the news and events in the world of IP!  First, a question to readers...In connection with comparative r...
- Friday, October 05, 2018
Friday Fantasies Friday Fantasies Reviewed by Dr Rose Hughes on Friday, October 05, 2018 Rating: 5
Top 10 issues from submissions before UK Supreme Court in Warner-Lambert v Actavis second medical use battle Top 10 issues from submissions before UK Supreme Court in Warner-Lambert v Actavis second medical use battle Reviewed by Eleonora Rosati on Thursday, February 22, 2018 Rating: 5
AIPPI Rapid Response Report: Debating Lyrica's recurring pain on plausibility, abuse and infringement AIPPI Rapid Response Report: Debating Lyrica's recurring pain on plausibility, abuse and infringement Reviewed by David Brophy on Thursday, December 08, 2016 Rating: 5
Pharma, Pain and Punditry: Mark your calendar for AIPPI's end of year events Pharma, Pain and Punditry: Mark your calendar for AIPPI's end of year events Reviewed by Annsley Merelle Ward on Tuesday, November 15, 2016 Rating: 5
Never Too Late: If you missed the IPKat last week! Never Too Late: If you missed the IPKat last week! Reviewed by Tian Lu on Wednesday, November 02, 2016 Rating: 5
Court of Appeal on Pregabalin - Pfizer still in pain, but Swiss claims re-interpreted again Court of Appeal on Pregabalin - Pfizer still in pain, but Swiss claims re-interpreted again Reviewed by Darren Smyth on Monday, October 24, 2016 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.